Table 1.
Cancer | MiRNA | Expression | Type of Samples | Targets | Biological Significance |
---|---|---|---|---|---|
CERVICAL CANCER | miR-21 | Upregulated [35,36,37] | Serum [37] Tissue [36] HeLa cell line [35,36,37] SiHa cell line [36] CaSki cell line [36] |
RASA1 [37] | Promoted cell migration and invasion [35,37] Associated with lymph node metastases [37] |
miR-155 | Upregulated [38] | Tissue [38] HeLa cell line [38] |
--- | Correlated with lymph nodes metastases and vascular invasion [38] Promoted cell migration and invasion [38] |
|
Upregulated [39] | CaSki cell line [39] |
SMAD2 [39] CCND1 [39] |
Decreased proliferation [39] Inhibited EGF-induced EMT, migration and invasion [39] Increased chemo-sensitivity [39] |
||
miR-218 | Downregulated [40,41] | Tissue [40,41] CaSki cell line [40] ME180 cell line [40] SiHa cell line [41] HeLa cell line [40,41] |
LAMB3 [40] SFMBT1 [41] DCUN1D1 [41] |
Associated with cell migration and invasion [40,41] Induction of EMT and invasion [41] |
|
miR-195 | Downregulated [42] | Tissue [42] HeLa cell line [42] SiHa cell line [42] |
DCUN1D1 [42] | Associated with lymph node metastases [42] Mediated cell proliferation, migration and invasion [42] |
|
miR-375 | Downregulated [43,44] | Tissue [43] SiHa cell line [43,44] CaSki cell line [43,44] |
SP1 [43] LncRNA MALAT1 [44] |
Correlated with pelvic lymph node metastases [43] Promoted cell proliferation, migration and invasion [43] Modulation of EMT [44] |
|
miR-124 | Downregulated [45] | Tissue [45] HeLa cell line [45] CaSki cell line [45] SiHa cell line [45] |
GRB2 [45] | Increased cell invasion [45] | |
miR-34a | Transfection with pre-miR-34a [46] | HeLa cell line [46] |
NOTCH1 [46] JAGGED1 [46] |
Repression of invasion [46] | |
miR-23b | Downregulated [47] | SiHa cell line [47] CaSki cell line [47] |
uPA [47] | Increased cell migration [47] | |
miR-214 | Downregulated [48] | Tissue [48] HeLa cell line [48] |
PLXNB1 [48] | Promoted cell proliferation, migration and invasion [48] | |
miR-205 | Upregulated [50] | Tissue [50] HeLa cell line [50] CaSki cell line [50] |
CYR61 [50] CTGF [50] |
Promoted cell proliferation and migration [50] | |
miR-133b | Upregulated [51] | Tissue [51] CaSki cell line [51] SiHa cell line [51] Female SCID mice [51] |
MST2 [51] CDC42 [51] RHOA [51] |
Enhanced cell proliferation and colony formation [51] In mice increased the number of lung metastatic foci [51] |
|
miR-125a | Downregulated [52] | Tissue [52] SiHa cell line [52] HeLa cell line [52] |
STAT3 [52] | Correlated with preoperative metastases [52] Modulation of EMT [52] |
|
miR-20b | Upregulated [53] | Tissue [53] HeLa cell line [53] SiHa cell line [53] CaSki cell line [53] |
TIMP2 [53] | Induced EMT, migration and invasion [53] | |
miR-146a-5p | Downregulated [54] | Primary HFKs cell line [54] HeLa cell line [54] SiHa cell line [54] CaSki cell line [54] |
KDM2B [54] | Promoted cell proliferation and migration [54] | |
miR-27b | Upregulated [55,56] | Tissue [55,56] CaSki cell line [55,56] SiHa cell line [55,56] |
PPARG [56] PLK2 [55] |
Promoted cell proliferation and invasion [55,56] | |
miR-106b-5p | Upregulated [57] | In silico studies [57] |
GSK3B [57] VEGFA [57] PTK2 [57] |
Correlated with the number of metastatic lymph nodes [57] |